TCB has an independent remuneration committee, comprised of independent board directors who decides on the level of executive remuneration. This committee meets annually.
Please email email@example.com and your query will be dealt with by our team.
Please visit https://beta.companieshouse.gov.uk/, search for TC BioPharm and click on ‘Filing History’.
TCB raises much of its funding from institutional investors, pharmaceutical collaborators and life science focused venture funds. However, if you would like to register an expression of interest, please email firstname.lastname@example.org.
TCB is represented in the UK by HBJ Gateley (Solicitors) and French Duncan LLP (accountants). TCB’s U.S. interests are represented by Golenbock Eiseman Assor Bell & Peskoe LLP (attorneys) and Joseph Gunnar & Co, LLC (lead financial advisors).
TCB is registered under the UK Companies Act 2006 (Company Number SC453579) and has its registered office at Maxim 1, 2 Parklands Way, Eurocentral, Holytown, Scotland, ML1 4WR